Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ONYX Pharmaceuticals
ONYX Pharmaceuticals
Onyx multiple myeloma drug wins FDA fast-track status
Bizjournals.com
Tue, 02/1/11 - 08:20 am
ONYX Pharmaceuticals
Multiple Myeloma
FDA
fast track
Carfilzomib
Interesting Biotech Picks for 2011
Seeking Alpha
Sun, 01/16/11 - 11:31 am
biotech
Cerus
Array Biopharma
ONYX Pharmaceuticals
Carfilzomib
Impax Laboratories
2011 Drugmaker M&A Targets
Motley Fool
Fri, 12/31/10 - 10:00 am
M&A
Pfizer
Merck
Genzyme
Sanofi
JNJ
Crucell
ONYX Pharmaceuticals
Bayer
Momenta
Novartis
GSK
Human Genome Sciences
Vertex Pharmaceuticals
MannKind
Vivus
Savient
Winners and Losers at the Hematology Society Meeting
Motley Fool
Wed, 12/8/10 - 06:54 pm
ONYX Pharmaceuticals
Seattle Genetics
Pfizer
Celgene
Immunogen
Novartis
Bristol-Myers Squibb
Takeda
JNJ
Changing the Perception of the Biotech One-Trick Pony
Seeking Alpha
Wed, 12/8/10 - 09:59 am
Alexion
Dendreon
ImClone
Exelixis
ONYX Pharmaceuticals
Onyx jumps on new data for cancer drug carfilzomib
Yahoo/AP
Tue, 12/7/10 - 12:08 pm
ONYX Pharmaceuticals
Carfilzomib
Onyx Drug’s Mild Side Effects Let Myeloma Patients Stay on It
Bloomberg
Mon, 12/6/10 - 11:02 am
myeloma
ONYX Pharmaceuticals
Carfilzomib
Biotech Calendar: Key Dates for December
TheStreet.com
Tue, 11/30/10 - 09:20 am
Delcath
Arena Pharmaceuticals
RXi Pharmaceuticals
Cell Therapeutics
Amgen
Incyte
Celgene
Corcept Therapeutics
Affymax
Targacept
Exelixis
Orexigen
ONYX Pharmaceuticals
Seattle Genetics
MannKind
Alimera
AstraZeneca
Human Genome Sciences
Virgin Market for New Bone Marrow Cancer Drug
Minyanville
Sat, 11/27/10 - 12:32 pm
Incyte
myelofibrosis
YM BioSciences
CYT387
ONYX Pharmaceuticals
Onyx lead gainer in drug sector
Marketwatch
Thu, 11/4/10 - 11:31 am
earnings
ONYX Pharmaceuticals
Novartis Halts Development of Two Drugs: Biotech's Latest Tribulations
Seeking Alpha
Mon, 10/11/10 - 11:20 am
Novartis
Actelion
AstraZeneca
Human Genome
JNJ
ONYX Pharmaceuticals
Pfizer
Rosetta Genomics
Targacept
Mycograb
albinterferon alfa-2b
Onyx Delays Cancer Drug Application As FDA Asks for More Data
Motley Fool
Fri, 10/8/10 - 08:12 am
ONYX Pharmaceuticals
FDA
Carfilzomib
Multiple Myeloma
Onyx Sells Japan Rights to Blood Cancer Drug
TheStreet.com
Wed, 09/8/10 - 07:36 am
ONYX Pharmaceuticals
Japan
Ono
Carfilzomib
3 Stocks to Play Biotech
Motley Fool
Mon, 08/9/10 - 02:17 pm
Dendreon
ONYX Pharmaceuticals
Geron
Isis Pharmaceuticals
InterMune
Onyx Reports Wider Loss
Yahoo/Zacks
Sat, 08/7/10 - 11:53 am
ONYX Pharmaceuticals
investors
earnings
Onyx Was Right to Acquire Proteolix All Along
Seeking Alpha
Tue, 07/27/10 - 11:47 am
ONYX Pharmaceuticals
Proteolix
Onyx's Next Blockbuster?
Forbes
Mon, 07/26/10 - 11:02 am
ONYX Pharmaceuticals
Carfilzomib
Multiple Myeloma
10 Firms Expecting Clinical Trial Results
TheStreet.com
Wed, 07/14/10 - 10:53 am
clinical trials
Ariad Pharmaceuticals
AstraZeneca
Biomarin
Bristol-Myers Squibb
Cyclacel
Corcept Therapeutics
Merck
ONYX Pharmaceuticals
Raptor Pharmaceuticals
Seattle Genetics
Onyx, Vivus rise on ratings boost
MarketWatch
Sat, 07/10/10 - 11:12 am
ONYX Pharmaceuticals
Vivus
Onyx, Bayer say Nexavar fails in lung cancer study
Yahoo/AP
Mon, 06/14/10 - 02:37 pm
Bayer
ONYX Pharmaceuticals
Nexavar
lung cancer
clinical trials
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
next ›
last »